deltatrials
Completed PHASE4 NCT00197808

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines

Sponsor: Public Health England

Conditions Meningococcal Infections Pneumococcal Infections
Interventions Men C Conjugate Men C conjugate Men C conjugate vaccine menjugate
Updated 7 times since 2017 Last updated: Sep 29, 2020 Started: Apr 30, 2005 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This PHASE4 trial investigates Meningococcal Infections and Pneumococcal Infections and is currently completed. Public Health England leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE4

  5. Sep 2018 — Oct 2020 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Public Health England
Data source: Public Health England

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Gloucester, United Kingdom
  • • Welwyn Garden City, United Kingdom